ClinHope is pleased to announce the official establishment of its Hong Kong branch, marking another important milestone in the company’s global expansion. Following its presence in Taiwan and the United States, ClinHope is further expanding its footprint in Asia and strengthening its global service network.
As the biotech, pharmaceutical, and medical device industries continue to expand across international markets, ClinHope remains committed to supporting clients through professional services in clinical research, regulatory affairs, quality management, and related consulting services, helping them navigate diverse market and regulatory requirements.
With its highly international business environment and strategic position connecting Asia with global markets, Hong Kong will serve as one of ClinHope’s key hubs in the Asia-Pacific region. Through this new presence, ClinHope will further strengthen regional partnerships and international collaboration while integrating expertise, resources, and market experience across Taiwan, the United States, and Hong Kong.
ClinHope CEO Abby Chang stated that the establishment of the Hong Kong branch represents an important milestone in the company’s globalization journey. Looking ahead, ClinHope will continue to expand its Asia-Pacific and global collaboration network, combining local expertise with an international perspective to provide professional services in clinical research, regulatory affairs, quality management, and related fields for the biotech, pharmaceutical, and medical device industries.
With operations now established in Taiwan, the United States, and Hong Kong, ClinHope will continue to strengthen its global network and cross-regional capabilities. By integrating professional expertise, local market experience, and resources across regions, ClinHope is committed to connecting Asian and global markets and becoming a trusted international professional services partner for its clients.
Connecting Asia. Expanding Globally.
As the biotech, pharmaceutical, and medical device industries continue to expand across international markets, ClinHope remains committed to supporting clients through professional services in clinical research, regulatory affairs, quality management, and related consulting services, helping them navigate diverse market and regulatory requirements.
With its highly international business environment and strategic position connecting Asia with global markets, Hong Kong will serve as one of ClinHope’s key hubs in the Asia-Pacific region. Through this new presence, ClinHope will further strengthen regional partnerships and international collaboration while integrating expertise, resources, and market experience across Taiwan, the United States, and Hong Kong.
ClinHope CEO Abby Chang stated that the establishment of the Hong Kong branch represents an important milestone in the company’s globalization journey. Looking ahead, ClinHope will continue to expand its Asia-Pacific and global collaboration network, combining local expertise with an international perspective to provide professional services in clinical research, regulatory affairs, quality management, and related fields for the biotech, pharmaceutical, and medical device industries.
With operations now established in Taiwan, the United States, and Hong Kong, ClinHope will continue to strengthen its global network and cross-regional capabilities. By integrating professional expertise, local market experience, and resources across regions, ClinHope is committed to connecting Asian and global markets and becoming a trusted international professional services partner for its clients.
Connecting Asia. Expanding Globally.